Skip to main content
. 2020 May 28;5(1):e000483. doi: 10.1136/tsaco-2020-000483

Table 2.

Comparison progression to no progression (increased hemorrhage)

Total study
n=269
No progression
n=239
Progression
n=30
P value
Age (years) 53.0 (31.0 to 67.1) 52.4 (30.3 to 67.0) 54.9 (33.0 to 75.4) 0.549
Female 120 (44.6%) 107 (44.7%) 13 (43.3%) 0.881
ISS 10 (8,16) 10 (6,16) 14 (9,19) 0.040
Admission GCS 15 (15,15) 15 (15,15) 15 (15,15) 0.469
Discharge GCS 15 (15,15) 15 (15,15) 15 (15,15) 0.707
NSG Consult 259 (95.9%) 230 (96.2%) 28 (93.3%) 0.789
SDH 138 (51.3%) 124 (51.9%) 14 (46.7%) 0.590
SAH 140 (52.0%) 129 (54.0%) 11 (36.7%) 0.074
EDH 7 (2.6%) 4 (1.7%) 3 (10.0%) 0.037
IPH 47 (17.5%) 37 (15.5%) 10 (33.3%) 0.015
Combined injuries 53 (19.7%) 46 (19.3%) 7 (23.3%) 0.596
Skull fracture 58 (21.6%) 48 (20.1%) 10 (33.3%) 0.096
ICU LOS (days) 1 (0 to 2) 1 (0 to 2) 1 (1 to 3) 0.015
LOS (days) 2 (2 to 4) 2 (1 to 4) 4 (2 to 9) 0.003

Continuous variables presented as median (IQR) and categorical variables presented as number (percentage).

EDH, epidural hematoma; GCS, Glasgow Coma Scale score; ICU, intensive care unit; IPH, intraparenchymal hematoma; ISS, Injury Severity Score; LOS, length of stay; NSG, neurosurgery; SAH, subarachnoid hemorrhage; SDH, subdural hematoma.